Severe acute respiratory syndrome-related coronavirus
| Alisporivir | SARS-CoV | — | Preclinical | — | Human CYPs | |
| Amiodarone | SARS-CoV | Non-competitive β-adrenergic inhibitor | Preclinical | — | Human (multiple) | |
| Amodiaquine | SARS-CoV | Methyltransferase inhibitor | Preclinical | — | Human HNMT | |
| Anisomycin | SARS-CoV | DNA synthesis inhibitor | Preclinical | — | Human ribosome | |
| Benztropine | SARS-CoV | Selective inhibition of dopamine transporters but it also presents affinity for histamine and muscarine receptors | Preclinical | — | Human CHRM1 | |
| Betulinic Acid | SARS-CoV | Unknown | Preclinical | — | Unknown | |
| Boceprevir | SARS-CoV | NS3/4a protease inhibitor | Preclinical | — | Viral protease | |
| Camostat | SARS-CoV | — | Preclinical | — | Human protease | |
| Cepharanthine | SARS-CoV | — | Preclinical | — | Unknown | |
| Chloroquine | SARS-CoV | Antimalaria agent; chemo/radio sensitizer | Preclinical | — | Human (multiple) | |
| Chlorpromazine | SARS-CoV | Inhibits assembly of clathrin-coated pits at the plasma membrane | Preclinical | — | Human (multiple) | |
| Clomipramine | SARS-CoV | — | Preclinical | — | Human (multiple) | |
| Cyclosporine | SARS-CoV | Calcineurin inhibitor; allows for inhibition of T cell activation | Preclinical | — | Human CYPs | |
| Dalbavancin | SARS-CoV | — | Preclinical | — | Unknown | |
| Dasatinib | SARS-CoV | Abl; Src; Kit; EphR... Inhibitor | Preclinical | — | Human PTK | |
| Emetine | SARS-CoV | — | Preclinical | — | Human ribosome | |
| Emodin | SARS-CoV | — | Preclinical | — | Human (multiple) | |
| Erlotinib | SARS-CoV | EGFR inhibitor | Preclinical | — | Human PTK | |
| Fluphenazine | SARS-CoV | Prevent viral entry | Preclinical | — | Human ion channel | |
| Galidesivir | SARS-CoV | RNA-dependent RNA polymerase (RdRp) inhibitor | Preclinical | — | Viral RNA pol | |
| Gemcitabine | SARS-CoV | Antimetabolite; Nucleoside analog | Preclinical | — | Viral RNA pol | |
| Glycyrrhizin | SARS-CoV | — | Preclinical | — | Human TNF | |
| GS-441524 | SARS-CoV | nucleoside analog | Preclinical | — | Viral RNA pol | |
| Hydroxychloroquine | SARS-CoV | Unclear | Preclinical | — | Human (multiple) | |
| Imatinib | SARS-CoV | Abl; Kit; PDGFRB inhibitor | Preclinical | — | Human PTK |